SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-24-061953
Filing Date
2024-07-17
Accepted
2024-07-17 09:06:54
Documents
14

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS ea0205334-09.htm 424B3 15689899
2 GRAPHIC tsilexion_logo.jpg GRAPHIC 44063
3 GRAPHIC tmoringa_logo.jpg GRAPHIC 62947
4 GRAPHIC tllan_sig.jpg GRAPHIC 6877
5 GRAPHIC tllan_sig1.jpg GRAPHIC 6880
6 GRAPHIC tflowchart_001.jpg GRAPHIC 269083
7 GRAPHIC tflowchart_002.jpg GRAPHIC 181117
8 GRAPHIC timage_001.jpg GRAPHIC 777327
9 GRAPHIC timage_002.jpg GRAPHIC 93871
10 GRAPHIC tlinechart_001.jpg GRAPHIC 140051
11 GRAPHIC tlinechart_002.jpg GRAPHIC 401142
12 GRAPHIC tpiechart_001.jpg GRAPHIC 280745
13 GRAPHIC timage_003.jpg GRAPHIC 500953
14 GRAPHIC tlinechart_003.jpg GRAPHIC 267996
  Complete submission text file 0001213900-24-061953.txt   19870293
Mailing Address 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 10177
Business Address 250 PARK AVENUE, 7TH FLOOR NEW YORK NY 10177 212-572-6395
Biomotion Sciences (Filer) CIK: 0002022416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-279281 | Film No.: 241121077
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)